Document is current
Any future updates will be listed below
-
Authors
Nurbhai, Suhail https://orcid.org/0000-0002-4218-9599
Roberts, Kevin J.
Carlton, Timothy M.
Maggiore, Luana
Cubitt, Marion F.
Ray, Keith P.
Reckless, Jill
Mohammed, Hafeez
Irving, Peter
MacDonald, Thomas T.
Vossenkämper, Anna
West, Michael R.
Parkes, Gareth C.
Crowe, J. Scott
-
Funding
Funding for this research was provided by:
VHsquared Ltd
- License Information
-
More Information
Article History
Received: 19 March 2019
Accepted: 15 September 2019
First Online: 1 October 2019
Competing Interests
: S.N., S.C., K.J.R., T.C., L.M., M.C., K.R. and M.W. are employees of VHsquared. A.V. received research funding from VHsquared and G.S.K., J.R. and H.M. received funding from VHsquared, S.C. has shares in VHsquared. T.T.M. received honoraria and/or research funding from Janssen, G.S.K., VHsquared, Grunenthal, Pfizer, Kymab, Topivert and Celgene. PI received fees for advisory work or speaking on behalf of AbbVie, Warner Chilcott, Takeda, M.S.D., ViforPharma, Pharmacosmos, Topivert, Genentech, Hospira, Samsung Bioepis, VH2, Janssen, Sandoz, Lilly, Ferring, Falk Pharma, Shire, Pfizer, Tillotts, and financial support for research from M.S.D. and Takeda. GP has received personal payments, honoraria or fees from AbbVie, Allergan, Ferring, Janssen, Napp, Takeda and Tillotts and travel grants or fellowships from AbbVie, Janssen, Takeda and Tillotts.
